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Grows More Success 1 Every 
by Mike Martin 
The 4th Annual Women's Leadership Luncheon to benefit The AIDS 
Project was held on October 6th at the Marriot at Sable Oaks in South 
Portland. This year's event was co-chaired by Donna Mundy and Terry 
Cohen of the UNUM Corporation, which was the Gold Ribbon sponsor of 
the event. Mary J. Herman, the first lady of the State of Maine, was the 
honorary chair. 
Receiving the Kerry A. Carson Memorial Awards were Cathy Kidman, 
Executive Director of Outright ( an organization serving gay, lesbian, 
bisexual, and transgendered young people ages 22 and under), and Mary 
Ruchinskas, Community Services Director ofNew Beginnings in Lewiston 
( an organization serving youth who are runaways, homeless, or in high risk 
situations). Both recipients spoke to the need of reaching out to youth to 
prevent the further spread of HIV, which already disproportionately affects 
people under the age of25. 
The Kerry A. Carson Memorial Awards pays tribute to Kerry Anne 
Carson ofYork, Maine, who contracted HIV at the age of 15 and later died of 
AIDS. Past recipients of the award include Kerry (posthumously), Frannie 
Peabody, Lani Graham, and Elizabeth Watson. 
Also participating was George Friou, TAP's Executive Director, who 
thanked all the sponsors, volunteers, and attendees for their support of 
people with HIV I AIDS. Stacy Bachelder from Telstar High School spoke to 
the crowd about her school's efforts to raise AIDS awareness and about her 
school's yearly fundraising benefit for a deserving AIDS organization. 
Mary Crothers and Bart Giamatti from Waynefleet School Students for 
Safer Sexuality performed an enlightening, yet humorous sketch concern-
ing safer sex. A sketch they would normally be presenting to their peers. 
Karla McGowan was singled out for all her hard work on the luncheon. 
Karla is a member ofTAP's Board of Directors and chair of its Fundraising 
& Public Relations Committee 
It was announced at the sold-out luncheon that the event had raised 
$18,000 for The AIDS Project. All in all, the Women's Leadership 
Luncheon has become an important annual area event to raise awareness of 
HIV/AIDS. 
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HIV News 
Teenagers in Turmoil 
USA Today (10/05/98) 
Many teenage deaths each year are avoidable, with 
approximately 10,000 of the 37,000 deaths among young 
people related to murder, suicide, or AIDS complications. 
HIV is increasingly becoming a problem among young 
people in the United States. The CDC says around 50% of 
the 40,000 new HIV cases in the U.S. occur in people under 
the age of 25. The CDC Youth Risk Behavior Surveillance 
Survey recently concluded that many teens were engaging 
in risky behaviors. Steve Small, a professor at the University 
of Michigan, also notes, ''They [adolescents] do things like 
drink and smoke and become sexually active". 
Despite widespread behavioral risks taken by teens, a 
CDC study indicates that sexual activity has declined 
among high school students for the first time in 20 years 
and that fewer students report having sex with a series of 
partners. The study of more than 10,000 students also 
shows that sexually active students were using condoms 
more often. Even though there has been a decline, one-tenth 
of all adolescents are sexually active before age 13, 
according to Janet Collins of the CDC. Suggestions from 
students at a recent CDC-sponsored meeting in Atlanta 
included increased positive role-modeling by parents and 
additional education initiatives. 
The Need for Improved Data on HIV Is Critical 
Boston Globe (10/03/98) 
Dr. Helene Gayle, of the CDC, asserts that some people 
have misinterpreted recent data on the HIV/AIDS epidemic. 
In a letter to the Boston Globe, Gayle notes that while the 
number of AIDS cases and deaths have declined, there is an 
increasing number of people living with HIV due to new 
treatments that slow disease progression. She points out 
that statistics on AIDS cases and deaths are important 
indicators of the epidemic among some groups of people for 
whom treatment is unavailable, yet the data does not 
indicate the number of new HIV infections, nor does it show 
how and where these infections are occurring. According to 
Gayle, "In order to get a clearer picture of the HIV/AIDS 
epidemic in Massachusetts and across the country, there is 
a need for improved data on HIV". She warns that people 
should be careful not to be misled by the decreasing number 
of AIDS cases and stresses the critical need for HIV 
prevention. 
Holding AIDS at Bay, Only to Face 'Lazarus Syndrome' 
New York Times (10/06/98) 
Protease inhibitor therapy has helped to increase the 
lifespans of many HIV-infected people, only to leave them 
attempting to adjust to what is--for many--life after death. 
A number of patients have seen their friends die from AIDS, 
and they face a harder life with the virus. Patients may face 
financial difficulties due to the cost of treatment or anxiety 
over the end of romantic relationships; some even become 
suicidal. Researchers have dubbed this anxiety the Lazarus 
Syndrome, named after the biblical figure who was raised 
from the dead by Christ. 
Dr. Judith Rabkin, a professor of clinical psychology at 
Columbia University, estimates that tens of thousands of 
HIV-infected people may have the syndrome. While the rigid 
medical regimen of protease inhibitor treatment may not 
directly cause the syndrome, it can contribute to the 
anxiety. Researchers note that the syndrome is unique to 
AIDS, but liken it to feelings of trauma suffered by Holocaust 
survivors. Both groups have seen their friends and families 
die and expected that they too would die, but were saved 
instead. Some advocacy groups are offering counseling to 
help patients deal with their emotions. 
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WAYlc..ha~ 
by MIKE MARTIN 
Fall is a season of change. The 
leaves are changing colors to magnifi-
cent shades of red and yellow and 
orange. Some wag once said that 
"change is the only constant." Well, I 
guess that's just about right. 
There have been a couple of staff 
changes at The AIDS Project. On the 
plus side, David Swander has joined the 
staff ... now I mentioned this last month, 
but I want to make sure he feels really 
welcome. David has taken on the 
additional duty of making sure this 
newsletter gets distributed. Thanks, 
David! And on the not-so-plus side, 
Rodney Mondor has left the Project for 
a job with the University of Southern 
Maine. Rodney brought a lot of energy 
and heart to his work as the Volunteer 
Services Coordinator. And he recently 
completed the Boston to New York 
AIDS Ride, for the second year in a row. 
Anyway, we'll miss his cheerful 
attitude and can-do enthusiasm. Good 
luck, Rodney! 
When you visit the Portland office 
of TAP, you will notice some changes in 
the lobby area. The changes are 
designed to provide even more profes-
sional service to clients and to improve 
on clients' comfort levels around 
confidentiality. 
On page five, I've reprinted TAP's 
Client Rights and Grievance 
Procedures. They haven't changed 
much over the years. Whoever wrote 
them did a pretty good job. Still, a 
refresher dose never hurts. 
On page six, I've reproduced a chart 
outlining anti-HIV drugs' dosages from 
Proj,ect Inform. I do so as a little service 
to clients because a client recently told 
me about how his doctor had under-
prescribed one of his drugs and how the 
Sources for some of the material in this 
newsletter include: 
The CDC Daily AIDS Update/Prevention News 
Project Inform, San Francisco, CA 
The next issue of In The Affirmative: 
Mid-November 1998 
client had built up a drug resistant 
because of this under-dosing. Of 
course, I recommend to all clients that 
they carefully consult and question their 
doctors when it comes to taking meds. 
One thing we know for sure, if you 
aren't taking the right amount of these 
drugs, you can build up a resistance 
pretty quickly. The treatments for HIV 
are constantly changing, with more 
options than ever before. But they won't 
do you any good, if you don't get them 
right. 
For those of you who participated in 
the Reconstruction programs this 
summer, I talked with Randy Norcross 
of the Maine AIDS Alliance and he tells 
me that followup from those sessions is 
in the thinking stages. In particular, the 
issues of going back to work and dating 
are on the list of things clients would 
like further workshops to address. 
A pleasant change was not that this 
year's Women's Leadership Luncheon 
was a big success (previous ones have 
been successful), but that the amount 
raised to benefit TAP in its work with 
people with HIV/AIDS was signifi-
cantly higher than last year. It was a 
grand event, and very moving. My 
congratulations to all who made it such 
a wonderful experience. 
Speaking of change, TAP will pick 
up a nice piece of change ($$$) through 
the sale ofWCLZ 98.9's "Homegrown, 
Volume 3" CD of local musical talent. 
Two dollars from each CD sold will be 
donated to TAP. They are available at 
Bull Moose Music stores. Thanks to 
WCLZ and Bull Moose Music for 
choosing TAP to be this year's recipient 
of their largesse. 
Change can be a good thing. 
Sometimes a very good thing. 
L 
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More HIV News 
Reporting HIV Casas Discussed 
Augusta Chronicle Online (09/23/98) 
Health officials in Georgia met in September to discuss 
the use of HIV reporting in the state. A decision on the 
matter is expected to be ready by summer 1999. Georgia is 
one of 11 states that does not currently report HIV cases. 
The state does report AIDS cases, but David Johnson, of the 
STD/HIV section of the Division of Public Health, said, "AIDS 
cases tell us what may have occurred 8-10 years ago, not 
what's occurring recently." Johnson also noted that the lack 
of HIV reporting could give people the false sense that the 
HIV epidemic is declining, since AIDS cases and AIDS 
deaths are falling. Some people voiced concerns that name-
or code-based HIV reporting would keep people from 
getting tested for HIV. There are an estimated 25,000 to 
30,000 HIV-infected individuals in Georgia, according to 
state officials. 
Reporting HIV Cases Is Urged at Hearing 
Boston Globe Online (09/23/98) 
Several AIDS activists spoke in favor of non-name based 
reporting of HIV cases at a hearing in September in 
Massachusetts. The measure discussed would require the 
reporting of HIV cases to the state Department of Public 
Health using a 17-digit identifier code that would encode 
information relating gender, age, and residence of the 
infected patient. Physicians would also be required to 
submit similarly coded information on patients already 
diagnosed with HIV. Bennett Klein, AIDS law project 
director for Gay and Lesbian Advocates and Defenders, 
asserts that "a non-name-based HIV reporting system 
responsibly balances the goal of obtaining more accurate 
and complete information about the HIV epidemic with the 
critical need to encourage HIV testing." Some fear that the 
system, which would go into effect on January 1, would 
result in the duplication of case reports, while others 
opposed the plan completely, arguing that name-based 
reporting is necessary in order to conduct partner 
notification. 
AIDS Deaths in U.S. Drop by Nearly Half 
New York Times (10/08/98) 
The AIDS mortality rate in the United States decreased 
by 46.4 percent in 1997, according to new data from the 
National Center for Health Statistics. There were 16,865 
deaths due to AIDS in 1997, as compared to 31, 130 deaths 
in 1996. The mortality rate decreased by a much greater 
margin than the previous record decrease, which measured 
29 percent from 1995 to 1996. The death rate fell to the 
lowest level since 1987--the first year AIDS deaths were 
tracked. AIDS ranked as the eighth leading cause of death in 
the United States in 1996, but fell to the 14th leading cause 
in 1997. 
However, the number of new HIV infections remained 
stable at about 40,000, indicating that there is a larger 
population of people living with the virus. The longer 
lifespan of infected people also means that there is an 
increased risk of the spread of the virus. Furthermore, some 
experts worry that the good news about the decrease in 
AIDS mortality will cause complacency. Health and Human 
Services Secretary Donna E. Shalala said the decline 
"reflects the tremendous power of the new combination 
therapies, the enormous effort to get the drugs to people 
and the huge Federal effort to pay for these drugs. What this 
also tells us is that we have serious problems when we 
have not brought down the rate of new infections." Some 
Wave of Laws Aimed at People Wrth HIV 
New York Times (09/25/98) 
Nationwide, laws that affect people with HIV are being 
passed following public fears about the spread of the 
disease. For example, at least 29 states now have laws 
making it a criminal offense to knowingly transmit HIV; 
one-third of the states adopted those laws within the last 
two years, and 16 states introduced such measures this 
year. Many states are also requiring HIV testing of certain 
populations, most notably prisoners and pregnant 
women. 
Four states recently passed laws allowing good 
Samaritans and non-medical personnel the right to inquire 
about the HIV status of the people they assist. Other states 
are increasing partner notification systems. According to 
some experts, the new laws result from a change in 
attitudes toward infected people; they also stem from 
growing publicity concerning specific cases of HIV 
transmission, such as the case of Nushawn Williams, 
who is accused of knowingly infected over a dozen girls 
and young women in New York. Lawrence 0. Gostin, a 
director of the Georgetown University-Johns Hopkins 
University Program on Law and Public Health and a 
member of the Centers for Disease Control and 
Prevention's advisory committee, said, "Legislators 
believe we have been soft on the epidemic, that we 
haven't treated AIDS like other infectious diseases, and 
the way they interpret it is a need to get tough on people 
with AIDS." 
The shift in public opinion is also tied to the change in 
prognosis for HIV-infected people. Protease inhibitor 
treatment has changed the perception of HIV infection 
from what was viewed as a fatal condition to a seemingly 
chronic disease. Additionally, a recent national phone 
survey of over 1, 700 people found that the public has 
become more suspicious of infected people, with 55 
percent of respondents in 1997 believing that they can 
contract HIV by sharing a glass with an infected person 
and 41 percent saying the virus might be acquired through 
the use of public toilets. Comparatively, 48 percent of 
respondents in 1991 believed they could get HIV through 
the sharing of a glass, while 34 percent thought they could 
get HIV from using public toilets. 
One of the authors of the study, social psychologist Dr. 
Gregory M. Herek, noted that the erosion of information 
could indicate that recent public health efforts have not 
underscored the fact that HIV is transmitted via sexual 
contact, contaminated hypodermic needles, or blood. 
Many public health officials are worried about the new 
criminalization laws and believe that the trend could result 
in HIV-infected people shying away from help. 
Maine Mother Is Allowed to Withhold AIDS Drug 
Washington Post (09/15/98) 
Recently, a Maine judge ruled that Valerie Emerson of 
Bangor, Maine has the right to refuse drug treatment for 
her HIV-infected four-year-old son, Nikolas. Emerson 
denied her son treatment, fearing that the powerful 
treatment would kill her child. 
The judge also ruled that Emerson could keep custody 
of the child, instead of turning the boy over to the state 
Department of Human Services. Emerson -- who is HIV-
positive and does not take medication either - said her 
decision stemmed from the death of her three-year-old 
daughter while on AZT, noting that she did not want 
Nikolas to go through the same process. 
State Agency Backs Off HIV Names Proposal 
Chicago Tribune Online (09/25/98) 
The Illinois Public Health Department has reversed a 
decision to require the names of HIV-positive people and 
will instead track HIV cases using non-name-based 
identifier codes. The decision came after months of public 
hearings and discussions with AIDS advocacy groups. 
AIDS advocates had expressed concern that the 
confidentiality of the reported individuals may be at risk. 
The health department said that it wanted to reach a 
compromise between activist concerns and surveillance 
needs. Officials noted that the new plan could be changed to 
name-reporting if it does not succeed; the pilot program will 
be launched on July 1, 1999, and evaluated in mid-2001. 
Chet Kelly, chief of the HIV/AIDS section for the 
Department of Public Health, said, ''There's no way to 
predict how it will work. If we didn't think it had any 
opportunity for success, we wouldn't propose it." 
DuPont Gets FDA Clearance For AIDS Drug 
Wall Street Journal (09/21/98) 
DuPont's pharmaceuticals division received FDA 
approval Friday to market its once-daily AIDS drug Sustiva, 
which the company says is as effective as the protease 
class of medicines when used with AZT and 3TC. The drug, 
which some analysts believe could generate $700 million in 
revenue a year, is the third non-nucleoside reverse 
transcriptase inhibitor (NNRTI) approved by the agency and 
is priced at about $11 a day in order to compete with 
protease drugs. Because the drug only needs to be taken 
once a day, DuPont believes Sustiva, a brand of efavirenz, 
will improve patient compliance and create a new standard 
of care. 
AIDS Group Protests DuPont's Pricing of New Drug 
Boston Globe Online (09/25/98) 
AIDS activists are protesting DuPont's decision to price 
its new AIDS drug, Sustiva, between $4,000 and $5,000, 
which some say could push individual drug therapy costs to 
about $30,000 per year. Members of ACT UP Philadelphia 
rallied outside DuPont's Wilmington, Del., headquarters, 
dumping empty pill bottles from a black coffin to underline 
its point. DuPont maintains that the drug is priced in the 
middle of the range for HIV/AIDS antivirals, and said it tried 
to price the drug so that the cost would not hinder access. In 
addition, the company said it would expand its therapy 
assistance program for the poor. 
Sustiva, which studies showed is as effective as 
Crixivan when taken in combination with AZT and 3TC, can 
lower the number of drugs patients take daily. 
Huge Gains and Huge Worries on AIDS 
New York Times (10/09/98) 
The medical advances that led to a 4 7 percent decline in 
the AIDS mortality rate last year are remarkable, yet there 
are still many HIV-infected individuals, according to an 
editorial in the New York Times. As many as 900,000 people 
in the United States carry the virus, with the rate of new 
infections steady at about 40,000 cases a year. With 
infected individuals living longer, the author argues that 
''there is an increasing danger that they will pass the virus 
on to others." The author also notes that HIV is spreading at 
alarming rates in parts of the developing world. where 
treatment access is very limited and financially restricted. 
Until a vaccine against the virus is created, the author 
contends that the HIV epidemic will continue to spread. 
researchers note that they are particularly concerned that Notice: Dignity/New England is sponsoring "A Time Apart-A Day for Caregivers." 
while the decline in AIDS mortality shows great strides This event is free and open to anyone involved in the care of a person with AIDS, and will be held on 
forward in treatment, prevention efforts have not been 
similarly successful because the number of new infections Saturday, October 31, 1998 from 9 am to 5 pm at St. Luke's Cathedral at 143 State Street in Portland. Lunch 
has remained level. and a massage therapist will be available. Call 646-2820 to register. ·-A~ 
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More HIV News 
African Growth Slows as Deaths Multiply 
Philadelphia Inquirer (09/27/98) 
United Nations demographers report that the effect of 
the AIDS epidemic on the population in some areas of Africa 
will be "unbelievable," according to one. Revised UN 
estimates for population growth will be released at the end 
of October, and some population experts believe that 
several countries in the region will reach zero population 
growth in a few years due to a combination of AIDS, food 
shortages, water depletion, social chaos, and ecological 
collapse. 
Zimbabwe is expected to be the hardest hit by the AIDS 
epidemic, with one-quarter of the population believed to be 
infected with HIV. Botswana also reportedly has a 25 
percent infection rate, while Namibia has a 20 percent rate, 
Zambia has a 19 percent rate, Swaziland has an 18.5 
percent rate, and several other African nations have rates 
over 10 percent. However, the spread of HIV is apparently 
slowing in some other countries, such as the United States, 
Brazil. Thailand, and Uganda. 
Worldwide population growth is expected to continue, 
with the population expected to reach 6 billion by mid-1999. 
AIDS on Rise Among SO-and-Overs 
Miami Herald (09/27/98) 
According to the Florida Department of Elder Affairs, 10 
percent of all AIDS cases in the United States occur in 
people over the age of 50 years, with rates reaching 12 
percent to 14 percent in Florida. Of 67,282 AIDS cases in 
Florida, 8,400 patients are age 50 or over. Despite these 
numbers, older people are often not considered at risk for 
HIV. 
Sue Saunders - a 65-year-old Fort Lauderdale woman 
with AIDS - started the AIDS activist group Senior HIV 
Intervention Project in response to this risk, receiving 
$170,000 from the Department of Elder Affairs to run a 
prevention group focusing on older people. Following the 
success of the initial program, the project spun off and a 
second group was formed in the Tampa Bay area. Saunders 
notes, ''You're never too old [to contract HIV]. And all it takes 
is one partner-if he or she is infected." 
Lower-Dose Regimen Works for Protease Inhibitor 
Reuters (09/25/98) 
Patients with AIDS may soon be able to take two doses 
of the protease inhibitor Viracept instead of three, Agouron 
said recently. The drug maker said 80 percent of 238 
patients taking a higher, twice-daily dosage of Viracept as 
part of a drug cocktail were able to lower the levels of the 
virus to a level that was almost undetectable. The response 
was similar to that achieved by patients taking the drug 
three times a day in a lower dosage. If the drug is approved, 
it may erode market share now held by Merck's Crixivan. 
Postexposure Treatment Not Easy to Swallow 
AIDS Alert (09/98) 
According to research by the Centers for Disease Control 
and Prevention, approximately one-third of health care 
workers who undergo HIV postexposure prophylaxis 
treatment {PEP) do not complete their regimen. Seventy-
five percent of the workers who halted treatment cited side 
effects as the determining factor. Side effects were also an 
issue with exposed workers who decided not to receive the 
treatment; only 58 of 114 exposed workers opted to receive 
PEP in the study. 
Research presented at the 12th World AIDS Conference 
in Geneva indicated that at least half of 100 occupational 
exposures to HIV investigated could have been prevented 
through proper work practices. 
Page Four 
U.S. House of Representatives' AIDS Notification 
Measure Praised, and Attacked by Prominent Groups 
Washington Times (09/30/98) 
At a House hearing in late September, the HIV Partner 
Protection Act -- which would require HIV-infected people 
to be reported confidentially by name instead of 
anonymous codes --was both praised and criticized. 
The bill, co-sponsored by Rep. Tom Coburn {R-Okla.) 
and Gary L. Ackerman {D-N.Y.). would also require doctors 
to supply the names of sexual partners named by the 
infected person to public health professionals, who could 
then notify those individuals. Ackerman told the House 
Commerce subcommittee on health and environment that 
the bill was particularly important for women, because 
many women with HIV were infected by partners who 
engage in high-risk behavior. However, Dr. Helene D. 
Gayle, head of the National Center for HIV, STD, and TB 
Prevention at the Centers for Disease Control and 
Prevention, asserted that the bill may cause people to 
avoid testing altogether due to confidentiality concerns. 
Gayle also noted that partner notification must be dealt 
with carefully, because it could result in domestic 
violence. 
Critics of the bill included the American Civil Liberties 
Union, AIDS Action, and the Association of State and 
Territorial Health Offices. The measure's supporters 
include the American Academy of Family Physicians; and 
directors of AIDS outreach programs in Florida, Brooklyn, 
New York, and Los Angeles. 
Patient Participation in HIV Treatment Plans 
Recommended to Improve Adherence 
Reuters Health Information SeNices (10/08/98) 
Dr. Barron H. Lerner, of Columbia University College of 
Physicians and Surgeons in New York City, and fellow 
researchers report in the October 1st issue of the Annals 
of Internal Medicine that anti-HIV drug regimen adherence 
may be increased by personalizing patient medication 
plans. The researchers recommend that patients first 
receive educational materials on the drugs, then the 
doctors should determine what patient lifestyle habits 
could affect adherence, and finally the patients should 
undergo a test regimen with dummy pills. 
The authors discourage strict categorization of patients 
as either adherent or non-adherent. They note that more 
flexible labeling and active participation by the patient in 
the regimen can prevent judgmental and inaccurate 
behavioral assessment and could increase treatment 
adherence. 
People Must Prove Exposure to HIV Before Suing, 
Supreme Court Says 
Postnet Online (10/02/98) 
The Illinois Supreme Court has ruled that patients who 
groundlessly feel they were put at risk for HIV due to 
medical care are not entitled to monetary damages. The 
court ruled against a woman who was cut by a scalpel in 
the office of an HIV-infected podiatrist. The woman, who 
worked as an aide in the office and cut herself while 
emptying a used sharps container, sued the two doctors 
at the office over fears that she may have been infected. 
The court also ruled against six patients who were treated 
by an HIV-positive dental student at Northwestern 
University. 
The judges said that proof of exposure is necessary to 
warrant damages and that fear of exposure was 
insufficient for compensation. David Holmes, one of the 
lawyers who represented one the defendants, said, "It's 
important that the justices draw the line. There's a lot of 
hysteria about AIDS." None of the plaintiffs contracted 
HIV, the virus that causes AIDS. 
Citing Privacy Rules, California Governor Wilson Vetoes 
Bill on HIV Reporting System • 
San Francisco Examiner Online (10/01/98) 
California Gov. Pete Wilson has vetoed legislation that 
would require the creation of a statewide HIV reporting 
system. San Francisco AIDS activists and public health 
officials expressed dismay at Wilson's action, asserting 
that the system would have been beneficial to public health. 
Wilson contends that the measure was flawed since the 
system would not be name-based and that "concerns over 
confidentiality and discrimination should not be used to 
justify an inadequate reporting system." 
California is one of nine states that does not require HIV-
reporting. Wilson, who is ending his final term this year, also 
signed a number of related bills this week, including a bill 
that mandates prison time for people convicted of 
knowingly transmitting HIV, a measure that requires 
emergency regulations for health care workers who sustain 
needlestick injuries, and a plan to institute a new red-ribbon 
license plate to raise money for AIDS research at the 
University of California. 
PRO.JECT 
Support Groups 
Looking for 
New Members 
Both the Tuesday morning and Thursday 
evening support groups sponsored by The 
AIDS Project are looking for new members. 
Both groups offer a safe and supportive 
space to share, listen, and connect with 
others. Please contact Susan Parr, TAP Case 
Manager, at 77 4-6877 for more info. 
The Tuesday morning group is open to 
anyone who is infected or affected by 
HIV/AIDS. The group serves family members, 
partners, relatives, and friends of those living 
with HIV/AIDS, along with persons lving with 
HIV/AIDS. Meetings are every Tuesday from 
10:30 a.m. to 12:00 noon in Suite 632 (TAP's 
Meeting Place) at 142 High Street in Portland. 
Joan Murray and Frannie Peabody facilitate 
the group. 
The Thursday evening support group is open 
to people living with HIV/AIDS. The group 
meets every Thursday from 5:30 p.m. to 7:00 
p.m. in Suite 632 (TAP's Meeting Place) at 
142 High Street in Portland. Audni Miller 
facilitates this group. 
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Reviewing Client Rights and the Client Grievance Procedures 
Editor's note: From time to time I try to resubmit information in this newsletter that directly pertains to client 
needs. Basic to the relationship of clients to The AIDS Project is how clients are treated and what rights they have 
concerning the policies and services of The AIDS Project. So,for your information, here is information I think 
all clients should have at their disposal. 
Client Rights 
As a client ofThe AIDS Project you have certain rights. They include: 
1. Considerate and respectful care. The right to receive considerate, dignified, and respectful treatment and care 
regardless of your physical or emotional condition, by all AIDS Project staff, interns, and volunteers. 
2. To be informed. The right to be informed of what services the agency provides, the method for obtaining those 
services, and the reasons why a service is not being provided. 
3. A reasonable and timely response. A response by a staff member in a reasonable and timely manner to your 
request(s) for services. 
4. Nondiscrimination. The right to quality services without discrimination as to race, color, age, disability, home-
lessness, religion, sex, national origin, economic status, or sexual orientation. 
5. Confidentiality. The right to expect that The AIDS Project will maintain the confidentiality of charts and records 
pertaining to the services you receive(d), except for otherwise provided by law. Any exceptions of confidentiality shall 
require you or your designee to sign a release of information. This does not apply to statistical data, which is required by 
funding agencies where the client's identity is not made known. 
6. Accessibility to your file. The right to request to review your file at a mutually agreed upon time with your case 
manager. Clients also have the rightto request a photocopy oftheir records. 
7. Grievance. The right to a formal grievance procedure in the event that you feel your rights as a client have been 
violated. 
Grievance Procedures 
The AIDS Project recognizes the importance of client rights with regard to the delivery of services which affect 
them. In keeping with this view, The AIDS Project has established grievance procedures through which clients may voice 
their concerns should an issue of dispute arise concerning policy or service delivery. 
1. The first step in any grievance procedure is to address the issue directly with the person(s) involved, [such as 
client and case manager]. 
2. If the parties directly involved cannot resolve the dispute within 5 working days, the matter will be described in 
writing* by the grieving party to the program coordinator, [ such as the Director of Support Services]. The coordinator shall 
attempt to achieve resolution with the parties involved. 
3. If, within 5 working days, the dispute still exists, the coordinator shall notify the Executive Director in writing. The 
Executive Director shall decide all matters related to the dispute within 15 days and provide the client written notification. 
4. If the grievance is not resolved to the satisfaction of the client, he or she may submit a written request to the 
President of the Board of Directors. A final binding decision will be made within 30 days of receipt of this request. 
*Persons voicing grievances regarding anonymous testing may do so using their client number, in order to protect 
their anonymity. 
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Standard Dosing Schedule for Anti-HIV Drugs (from Proiect Inform) 
Name Brand Name Class 
lndinavir Crixivan® Protease 
Inhibitor 
Nelfinavir Viracept® Protease 
Inhibitor 
Ritonavir Norvir® Protease 
Inhibitor 
Saquinavir Fortovase®, Protease 
lnvirase® Inhibitor 
Delavirdine Rescriptor® NNRTI 
Nevirapine Viramune® NNRTI 
AZf Retrovir®, NARTI 
zidovudine 
AZf +3TC Combivir® NARTI 
ddC Hivid®, NARTI 
zalcitabine 
ddl Videx®, NARTI 
didanosine 
d4T Zerit®, NARTI 
stavudine 
3TC Epivir®, NARTI 
lamivudine 
~ PageSix 
Standard Daily Dose Comments 
Two 400-mg capsules Take on empty stomach, at least 1 hour before or 2 hours after a meal; do not 
three times a day take at same time as ddl, take indinavir at least 1 hour before or 2 hours after 
ddl; to reduce risk of kidney stones, drink 8 glasses of water a day; must be 
taken every 8 hours. 
Three 250-mg tablets Should take with food; diarrhea is a common side effect that is usually 
three times a day controlled with over-the counter medication. 
Six 100-mg capsules Diarrhea and nausea may appear, is worse in first few weeks; needs to be 
twice a day refrigerated, consult doctor for initial dosing schedule (start at 300-mg twice 
a dayfor2 days and increase 100-mg every 2 days until you reach 600-mg). 
Fortovase -Six 200-mg capsules Take with food, within 2 hours of high fat meal; diarrhea and nausea are rare 
three times a day side effects. 
lnvirase -Three 200-mg capsules 
three times a day 
Four 100-mg tablets Take with or without food; can be dissolved in water or other liquids if drank 
three times a day immediately; a severe rash could develop (usually within first 3 weeks) and 
require hospitalization or milder rash which can be controlled by antihista-
mines or topical agents. 
1 200-mg tablet Dose usually starts at one 200-mg tablet and then increased to two 200-mg 
twice a day tablets after 14 days; take with or without food; a severe rash could develop 
(usually within first 3 weeks) and require hospitalization or milder rash which 
can be controlled by antihistamines or topical agents. 
Two 100-mg capsules Take with or without food; common side effects (which diminish after 6 to 8 
twice a day weeks) include headache, nausea, and a general sense of feeling ill; most 
or 1 300-mg tablet serious side effect is anemia, if caught early can be treated with erythropoie-
twice a day tin(EPO). 
1 tablet (with 150-mg 3TC, 300-mg AZT) Take with or without food; see comments in AZf and 3TC sections. 
twice a day 
Three 0.75-mg tablets Take with or without food; side effects can include pain or tingling in hands 
three times a day and/or feet, low platelets, and mouth sores; the most serious side effect is 
pancreatitis, which has been fatal in some people -- symptoms include sharp 
pain in upper abdomen, nausea, and vomiting, stop drug immediately and 
consult your doctor. Alcohol use increases risk of pancreatitis. 
Two 100-mg tablets Take without food and on an empty stomach; do not take within 2 hours of 
twice a day drugs that require an acidic stomach environment, including many protease 
inhibitors and drugs such as dapsone; side effects could include increased 
uric acid levels (kidney function), headaches, sleeplessness, diarrhea, and 
pain and/or tingling in hands and/or feet; the most serious side effect is 
pancreatitis, which has been fatal in some people -- symptoms include sharp 
pain in upper abdomen, nausea, and vomiting, stop drug immediately and 
consult your doctor. Alcohol use increases risk of pancreatitis. 
Two 40-mg capsules Take with or without food; common side effects are pain and/or tingling in 
twice a day hands and/or feet and anemia; a rare, but serious side effect is pancreatitis, 
which has been fatal in some people -- symptoms include sharp pain in upper 
abdomen, nausea, and vomiting, stop drug immediately and consult your 
doctor. Alcohol use increases risk of pancreatitis. 
Two 150-mg tablets Take with or without food; side effects are rare, but may include headaches, 
twice a day nausea, general sense offeeling ill, diarrhea, anemia, and hair loss. 
NNRTI = Non-nucleoside reverse transcriptase inhibitor NARTI = Nucleoside analogue reverse transcriptase inhibitor 
For more info, call the National HIV/AIDS Treatment Hotline at 1-800-822-7422 
In The Affirmetive © October 1998 from Bald Man Publishing for The A/OS Project Portland, ME 
[l)IIIIIISERVICES I 
MEDICAL ASSISTANT FUNDS 
An important reminder to clients: 
There are funds available to TAP clients with financial need for the 
following items: Routine Dental Care, Routine Eye Care and 
Eyeglasses, Vitamin Supplements, Non-Prescription Skin Care 
Products, and Non-Medicaid Medication Co-pays. 
There is a dollar limit to how much a client can receive in any fiscal 
year. Contact your case manager for assistance. 
FREE LUNCH 
Enjoy a free lunch at The AIDS Project every Thursday at noon. Join 
other clients and TAP staff for a great meal, good conversation, and 
very good company. Drop on by Thursdays at noon! 
IMMEDIATE SEATING 
For free tickets to area events as they become available, sign up for 
"Immediate Seating." Call TAP at 774-6877 for more information. 
I.V LEAGUE 
Meetings of the I.V. League support group are held on 
Wednesdays at 11 :00 a.m. at the Parkside Community 
Center, 94 Mellen Street, in Portland. 
For more information, call 874-8775. 
THE MEETING PLACE 
This room is used by TAP in Portland for support groups, counseling 
and testing, and some clienVcase manager meetings. Located in 
Suite 632, it provides more privacy for people served by TAP. 
Enter from the High Street side of the building. 
11111;u1ll)#JINFORMATION I 
HIV WEBSITES 
Check out these websites: 
www.hivpositive.com 
www.thebody.com 
www.projinf.org 
for info on HIV and AIDS. 
TAP ON-LINE 
Visit our web address at 
"www.aidsproject.org" 
To e-mail The AIDS Project, 
send your message along to 
"tap@aidsproject.org" 
AIDS HOTLINES 
Questions about 
HIV/AIDS? 
Call toll-free 
National AIDS Hotline: 
1-800-342-2437 
Maine AIDSline: 
1-800-851-2437 
Maine Teen Hotline: 
1-800-851-2437 
TAP's MAILING ADDRESS 
When writing to TAP in Portland, please send your mail to our post 
office box. It really rushes mail delivery if letters are not addressed 
to our street address, 
so write us at P. 0. Box 5305, 
Portland, ME 04101 
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FOR PEOPLE INFECTED 
AND AFFECTED BY HIV/AIDS 
TUESDAYS 
Time: 10:30 a.m. to noon 
Group: HIV Infected/Affected Drop-In Support Group 
A meeting for people living with and affected by the virus. 
Location: Portland, TAP, The Meeting Place, Suite 632. 
Contact Randy May at TAP at 774-6877 for more information. 
Time: 1 :30 p.m. to 3:00 p.m. 
Dates: Starts September 22nd, Meets every other Tuesday 
Group: Women with HIV 
A bi-weekly meeting of women living with HIV. 
Sponsored by The AIDS Project (TAP) 
and The AIDS Consultation Service (ACS) 
at Maine Medical Center. 
Location: Portland, ACS, 52 Gilman Street. 
Contact Janine Collins at TAP at 774-6877 
or Cindy Luce at ACS at 871-2991 for more information. 
Time: 1 :30 p.m. to 3:00 p.m. 
Group: People Uving with HIV 
An ongoing drop-in support group for people living with HIV. 
Location: Auburn, TAP, One Auburn Center. 
Contact Diana Carrigan at TAP at 783-4301 for more info. 
THURSDAYS 
Time: 10:00 a.m. to 11:30 a.m. 
Group: HIV Infected/Affected Drop-in Group 
A TAP-sponsored meeting for people 
living with and affected by HIV/AIDS in southern Maine. 
Location: Sanford, Unitarian Church, located at the corner of 
Main St. (Rte. 109) and Lebanon St. (Rte. 202). 
Contact Getty Payson at TAP at 985-8199 for more info. 
Time: 12 noon 
Group: Open Lunch for TAP Clients/Staff 
An informal luncheon gathering of TAP staff and clients. 
Location: Portland, TAP, Conference Room. 
Contact Randy May at TAP at 774-6877 for more information. 
Time: 5:30 p.m. to 7:00 p.m. 
Group: People Living with HIV/AIDS 
A drop-in support group for anyone with HIV/AIDS. 
Location: Portland, TAP, The Meeting Place, Suite 632. 
Contact Randy May at TAP at 774-6877 for more information. 
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The AIDS Project 
615 Congress Street 
(or 142 High Street) 
P.O. Box 5305 
Portland, Maine 04101 
Phone: 774-6877 Fax: 879-0761 
E-mail: tap@aidsproject.org 
Website: www.aidsproject.org 
AIDS Hotline: 775-1267 
or 1-800-851-2437 
Oxford/ Androscoggin Cty. Office 
One Auburn Center/Box 14L 
Auburn, ME 04210 
Phone: 783-4301 Fax: 795-4084 
York County Office 
Lafayette Center • 4th Floor 
Kennebunk, ME 04043 
Phone: 985-8199 Fax: 985-8646 *51 
Staff: 
Doug Bailey, 
HAVEN Project Coordinator 
Declan Buckley, 
Prevention Ed Outreach Worker 
Diana Carrigan, 
Case Manager 
Janine Collins, 
Case Manager 
John Cronin, 
Prevention Ed Outreach Worker 
Sequoia Dance, 
Prevention Ed Outreach Worker 
Douglas Eaton, 
Prgrm. Coord./HIV Prevention 
Jill Frame, 
HAVEN Case Manager 
George W. Friou, 
Executive Director 
Demetra Giatas, 
Development Director 
John Green, 
Case Manager 
John Holverson, 
Director of Policy & Program 
Randy May, 
Director of Support Services 
Rebecca Neel, 
Case Manager 
Susan Parr, 
Case Manager 
Getty Payson, 
Case Manager 
Linda Pfaffinger, 
Community HIV Prevention Ed 
Steve Reevy, 
Di rector/Finance/ Administration 
Gerry Scoppettuolo, 
Prevention Ed Outreach Worker 
David Swander. 
Administrative/Development Asst. 
Arthur Waller 
Accounting Assistant 
Board of Directors: 
Joel C. Martin, Esq., President 
Michael Martin, Vice President 
Anne M. Romano, CPA, Treasurer 
JoAnne Peterson, Secretary 
Lawrence Bliss 
Michael Burnham 
Jerrold C. Edelberg, Ph.D. 
Dino Giamatti 
Judi Mansing 
Karla B. McGowan 
Frances W. Peabody 
John Wade 
Christopher Warner 
IIIIIIIIAFFIRMATIVI 
In The Affirmative is a monthly newsletter published by The AIDS 
Project for people living with and affected by HIV/ AIDS. Letters, articles, 
or other submissions should be sent to: In The Affirmative, c/o The AIDS 
Project, P.O. Box 5305, Portland, ME 04101, or call (207) 774-6877. 
Submissions can be printed anonymously as long as the person 
submitting the material includes his or her name and phone number for 
verification. 
News, information, and features are as up-to-date as possible prior to 
publication. Any medical information included in this newsletter is 
submitted for the reader's information only, to be used as the reader so 
chooses. 
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